BlackRock Fund Advisors - CHELSEA THERAPEUTICS INTL LT ownership

CHELSEA THERAPEUTICS INTL LT's ticker is CHTP and the CUSIP is 163428105. A total of 70 filers reported holding CHELSEA THERAPEUTICS INTL LT in Q3 2013. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of CHELSEA THERAPEUTICS INTL LT
ValueSharesWeighting
Q1 2014$12,075,000
+29.1%
2,187,418
+3.7%
0.00%
+33.3%
Q4 2013$9,356,000
+64.5%
2,109,631
+10.9%
0.00%
+50.0%
Q3 2013$5,688,000
+47.1%
1,902,295
+13.1%
0.00%
+100.0%
Q2 2013$3,868,0001,681,8020.00%
Other shareholders
CHELSEA THERAPEUTICS INTL LT shareholders Q3 2013
NameSharesValueWeighting ↓
MILLENNIUM MANAGEMENT LLC 100,000$13,400,0000.04%
WHITEBOX ADVISORS LLC 2,777,092$555,0000.02%
CSS LLC/IL 45,000$290,0000.01%
Polar Asset Management Partners Inc. 750,000$60,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 396,300$2,584,0000.00%
NORTHERN TRUST CORP 648,574$4,229,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 56,400$368,0000.00%
AMERIPRISE FINANCIAL INC 30$00.00%
DEUTSCHE BANK AG\ 23$00.00%
CITIGROUP INC 74$00.00%
View complete list of CHELSEA THERAPEUTICS INTL LT shareholders